AI vs Radiologists: Where Each One Actually Wins in 2026
AI vs radiologists, scored task by task: where diagnostic AI beats human doctors on mammograms, where it ties, and where it still loses badly.
AI vs radiologists, scored task by task: where diagnostic AI beats human doctors on mammograms, where it ties, and where it still loses badly.
Hypershell vs Dnsys: compare price, power, battery and the safety data on the two consumer exoskeletons shipping in 2026, plus who should skip both.
Tesla Optimus vs Figure 03 vs Unitree G1: which humanoid robot actually ships in 2026? Real prices, specs, deployments, and the one you can…
Best AI agent frameworks 2026: LangGraph, CrewAI, AutoGen and vendor SDKs compared on control, maturity and lock-in risk, plus how to judge the claims.
GPT-5.2 vs Gemini 3 vs Claude Opus 4.5: three flagships in 24 days, benchmark gaps under a point. Here is what actually separates them…
Enigma robots.online lets anyone pilot 100+ real robots after a $71M seed. But who really trains the robotic brain when strangers hold the controls?
Proof scarcity to proof abundance: Terence Tao says AI now writes proofs faster than mathematicians can read them. Here's what that shifts for all…
Double neural bypass restored movement and touch to a paralyzed man — and the gains outlasted the machine. Here's why that changes what BCIs…
AI model welfare research is now a real field at Anthropic, DeepMind, and Meta. Who's studying whether models can suffer - and whether it…
AI music labeling just went industry-wide. But does a 'generated vs assisted' tag actually tell us who authored a song? The gaps are bigger…
Anthropic AI drug discovery is here with Claude Science and an in-house drug program. What it means for patients, neglected diseases, and trust in…
The first FDA-cleared neuromodulation wearable for PTSD just arrived. Here's how Modius Spero works and what it means for cognitive-health tech.
AI biological age clocks promise a truer age than your birthday. Here's what they actually measure, where they fail, and who might read your…
OpenAI government stake AI governance explained: what a 5% US equity stake worth ~$42.6B means for accountability, safety, and the regulator-shareholder clash.
Is AI training on copyrighted work fair use? Here's what the Thomson Reuters v. Ross ruling and the Third Circuit appeal mean for writers…
Neuralink vs Synchron vs Paradromics: a clear, human-first comparison of electrode counts, safety, patients, and the regulatory race in brain-computer interfaces.
RLHF vs Constitutional AI vs mechanistic interpretability, explained in plain terms: what each safety method catches, where it fails, and which to trust.
The Midjourney ultrasound scanner promises a 60-second full-body scan. Can an AI famous for hallucinating images be trusted to picture your insides?
Neuralink Blindsight human trials aim to restore vision by writing signals into the brain. Here is what the science really promises, and what it…
AI-designed rare-earth-free magnets made headlines, but what did Ames Lab actually build? We untangle DuctGPT, the roadmap, and China's magnet grip.
AI weather forecasting at NOAA now runs a 16-day outlook in 40 minutes. But who is accountable when the model, not a person, calls…
Are long-horizon AI agents functionally AGI? We weigh Sequoia's 2026 claim, METR's task-horizon curve, and the reliability math skeptics keep citing.
AI red-teaming now has professional attackers probing models on purpose. Here's what they find, why 2026 made it a discipline, and what it means…
The Paradromics speech-restoring brain-computer interface just got a first-ever FDA nod. Here's what it means for people who can't speak, minus the hype.